Novartis’ Valsartan in Government Crosshairs Again, This Time in Japan

Drug Industry Daily
A A
Novartis’ valsartan woes escalated Thursday as Japan followed the U.S. in filing a legal complaint against the Swiss drugmaker over its marketing practices for the blood pressure drug.

To View This Article:

Login

Subscribe To Drug Industry Daily